Ranelagh PTE
Alodokter: Chat Bersama Dokter
Publisher DNA
What defines Ranelagh PTE?
AI intelligence is not yet available for Ranelagh PTE. The portfolio data below is up to date.
Portfolio
What does Ranelagh PTE ship?
Apps
2 apps analysed
20,000+ provider network provides scale for on-demand care
- Direct communication with medical professionals provides helpful and detailed health guidance for users
- Automated AI responses replace human doctors and frustrate users seeking personalized medical attention
Analysis in progress
Single-market publisher, every app ships only to United States.
Based on 1 of 2 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (1)
- United States1 / 1
Core markets (1/1 apps)
User Sentiment
How do users feel about their apps?
0
Positive apps
0
Neutral / mixed
1
Negative apps
25/100
Avg sentiment score
Rivals
Who does Ranelagh PTE compete with?
The rivals identified
Nemeses(1)
Teladoc serves as the global benchmark for end-to-end virtual care, matching Alodokter's super-app ambition with a massive, highly active user base.
Contenders(3)
MDLIVE is a direct competitor in the virtual urgent care space, focusing on rapid, on-demand medical consultations.
One Medical represents the gold standard for hybrid care, blending digital convenience with physical clinic access.
Zocdoc dominates the appointment booking vertical with a highly refined UX that Alodokter's booking feature must compete against.
Same space(2)
Sydney Health represents the 'payer-as-app' model, providing a comprehensive health dashboard for insurance members.
GoodRx serves as a critical adjacent player in the pharmacy savings space, a key component of Alodokter's value proposition.
New entrants(1)
NimbleRx is aggressively iterating on the pharmacy delivery experience with a high release cadence.